tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

BHVN Stock Latest News

Biohaven Ltd. Highlights Strategic Focus in Investor Presentation
Company AnnouncementsBiohaven Ltd. Highlights Strategic Focus in Investor Presentation
3d ago
8K
BHVN
3 Best Stocks to Buy Now, 6/2/2025, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 6/2/2025, According to Top Analysts
5d ago
BHVN
DKNG
3 Best Stocks to Buy Now, 5/30/2025, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 5/30/2025, According to Top Analysts
8d ago
BHVN
DKNG
Biohaven Ltd. Receives Buy Rating from Douglas Tsao Amid Promising R&D Advancements and Strategic Developments
PremiumRatings
Biohaven Ltd. Receives Buy Rating from Douglas Tsao Amid Promising R&D Advancements and Strategic Developments
8d ago
BHVN
Biohaven Ltd. Receives Buy Rating Amidst Promising Developments and Strategic Advancements
PremiumRatings
Biohaven Ltd. Receives Buy Rating Amidst Promising Developments and Strategic Advancements
8d ago
BHVN
Biohaven initiates global Phase 2/3 study of BHV-8000
PremiumThe FlyBiohaven initiates global Phase 2/3 study of BHV-8000
9d ago
BHVN
Optimistic Buy Rating for Biohaven Ltd. Amid Promising Pipeline and Regulatory Challenges
Premium
Ratings
Optimistic Buy Rating for Biohaven Ltd. Amid Promising Pipeline and Regulatory Challenges
9d ago
BHVN
Biohaven Ltd.: Promising Pipeline and Undervaluation Justify Buy Rating
Premium
Ratings
Biohaven Ltd.: Promising Pipeline and Undervaluation Justify Buy Rating
9d ago
BHVN
Biohaven announces ‘positive’ TRAP degrader data
PremiumThe Fly
Biohaven announces ‘positive’ TRAP degrader data
10d ago
BHVN
Biohaven provides oncology program update
PremiumThe Fly
Biohaven provides oncology program update
10d ago
BHVN
MRUS
RBC downgrades Biohaven to Sector Perform on regulatory risk
PremiumThe Fly
RBC downgrades Biohaven to Sector Perform on regulatory risk
19d ago
BHVN
Biohaven downgraded to Sector Perform from Outperform at RBC Capital
PremiumThe Fly
Biohaven downgraded to Sector Perform from Outperform at RBC Capital
19d ago
BHVN
Biohaven falls -16.8%
PremiumThe FlyBiohaven falls -16.8%
23d ago
BHVN
Biohaven falls -17.5%
Premium
The Fly
Biohaven falls -17.5%
23d ago
BHVN
Biohaven falls -17.0%
Premium
The Fly
Biohaven falls -17.0%
23d ago
BHVN
Biohaven Ltd.’s Resilience and Strategic Growth Potential Amidst Regulatory Challenges
PremiumRatings
Biohaven Ltd.’s Resilience and Strategic Growth Potential Amidst Regulatory Challenges
23d ago
BHVN
Biohaven’s Troriluzole PDUFA Date Extended by FDA
PremiumCompany Announcements
Biohaven’s Troriluzole PDUFA Date Extended by FDA
23d ago
8K
BHVN
Biohaven Ltd. Receives Buy Rating Amid Promising FDA Progress and Strong Financial Position
PremiumRatings
Biohaven Ltd. Receives Buy Rating Amid Promising FDA Progress and Strong Financial Position
23d ago
BHVN
Closing Bell Movers: Foot Locker up nearly 70% on Dick’s buyout
PremiumThe Fly
Closing Bell Movers: Foot Locker up nearly 70% on Dick’s buyout
24d ago
FL
DKS
FDA extends PDUFA for Biohaven’s Troriluzole new drug application
PremiumThe FlyFDA extends PDUFA for Biohaven’s Troriluzole new drug application
24d ago
BHVN
Biohaven Ltd. Receives ‘Buy’ Rating Due to Promising Pipeline and Favorable Regulatory Progress
Premium
Ratings
Biohaven Ltd. Receives ‘Buy’ Rating Due to Promising Pipeline and Favorable Regulatory Progress
24d ago
BHVN
Biohaven price target lowered to $54 from $61 at RBC Capital
Premium
The Fly
Biohaven price target lowered to $54 from $61 at RBC Capital
25d ago
BHVN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >